BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Droxidopa (Northera) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Droxidopa (Northera)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT01370512-1776@assetmemo.bio
DTSTAMP:20261121T005603Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:Droxidopa (Northera): Phase 2 readout est. (NCT01370512)
DESCRIPTION:Droxidopa (Northera)\, phase 2.\nStudy: Droxidopa / Pyridostigm
 ine in Orthostatic Hypotension\nEstimated primary completion: May 2027. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/droxidopa-northera#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT01370512
URL:https://assetmemo.bio/drug/droxidopa-northera#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06937307-1776@assetmemo.bio
DTSTAMP:20261121T005603Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Droxidopa (Northera): Phase 2 readout est. (NCT06937307)
DESCRIPTION:Droxidopa (Northera)\, phase 2.\nStudy: Droxidopa to Increase M
 ean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidne
 y Injury\nEstimated primary completion: 31 December 2027. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/droxidopa-northera#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT06937307
URL:https://assetmemo.bio/drug/droxidopa-northera#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07398508-1776@assetmemo.bio
DTSTAMP:20261121T005603Z
DTSTART;VALUE=DATE:20300630
DTEND;VALUE=DATE:20300701
SUMMARY:Droxidopa (Northera): Phase 1/2 readout est. (NCT07398508)
DESCRIPTION:Droxidopa (Northera)\, phase 1/2.\nStudy: NORTHERA (DROXIDOPA) 
 for Dysautonomia in Pediatric Survivors of Menkes Disease\nEstimated prima
 ry completion: 30 June 2030. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/droxidopa-northera#upcoming-events\nRegistry record: https://clini
 caltrials.gov/study/NCT07398508
URL:https://assetmemo.bio/drug/droxidopa-northera#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
